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Background: Production of recombinant proteins in bacteria for academic and commercial purposes is a well
established field; however the outcomes of process developments for specific proteins are still often unpredictable.
One reason is the limited understanding of the performance of expression cassettes relative to each other due to
different genetic contexts. Here we report the results of a systematic study aiming at exclusively comparing
commonly used regulator/promoter systems by standardizing the designs of the replicon backbones.
Results: The vectors used in this study are based on either the RK2- or the pMB1- origin of replication and contain
the regulator/promoter regions of XylS/Pm (wild-type), XylS/Pm ML1-17 (a Pm variant), LacI/PT7lac, LacI/Ptrc and AraC/
PBAD to control expression of different proteins with various origins. Generally and not unexpected high expression
levels correlate with high replicon copy number and the LacI/PT7lac system generates more transcript than all the
four other cassettes. However, this transcriptional feature does not always lead to a correspondingly more efficient
protein production, particularly if protein functionality is considered. In most cases the XylS/Pm ML1-17 and LacI/
PT7lac systems gave rise to the highest amounts of functional protein production, and the XylS/Pm ML1-17 is the
most flexible in the sense that it does not require any specific features of the host. The AraC/PBAD system is very
good with respect to tightness, and a commonly used bioinformatics prediction tool (RBS calculator) suggested
that it has the most translation-efficient UTR. Expression was also studied by flow cytometry in individual cells, and
the results indicate that cell to cell heterogeneity is very relevant for understanding protein production at the
population level.
Conclusions: The choice of expression system needs to be evaluated for each specific case, but we believe that
the standardized vectors developed for this study can be used to more easily identify the nature of case-specific
bottlenecks. By then taking into account the relevant characteristics of each expression cassette it will be easier to
make the best choice with respect to the goal of achieving high levels of protein expression in functional or non-
functional form.
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Parameters affecting recombinant protein expression in
Escherichia coli have been studied extensively and nu-
merous methods aiming at improving protein yields have
been reported, usually involving genetic manipulations
and/or production process optimization [1-4]. However,
in spite of the large number of potentially useful ap-
proaches available there is still no guarantee that a satis-
factory result will be obtained in each specific case, and
trial and error is therefore currently an integrated part
of development of new protein production processes.
The work involved in this can become very laborious
since many parameters such as choice of strains, vector
construct designs, growth media and cultivation condi-
tions can potentially have a big and unpredictable effect
on the process. Steadily more promoter systems for reg-
ulated protein expression in E. coli ([1] and references
therein, [2-6]) are being developed, increasing the com-
plexity. The studies of those novel expression systems were
commonly based on experiments involving vectors with
different backbones [2,4,7,8]; typically commercially avail-
able and commonly used vectors from the pET [9], pTrc
[10] or pBAD [11] series. More theoretical approaches have
also been used [6,12]. However, expression is influenced by
many parameters even within vectors, like the presence or
absence of sequences of the 50 coding region encoding N-
terminal fusion partners (His6 tag [13], N-terminal signal
peptides [14], and others), different origins of replication
[15-17], different terminators [18] or selection markers.
Penicillins for example are very frequently used for se-
lection in spite of their known rapid degradation due to se-
creted β-lactamase [19]. A first step towards a more
systematic, backbone-independent approach is described
in a study performed by Tegel et al. [20] in which ex-
pression from three different IPTG-inducible promoters
(PT7lac, Ptrc, Plac) is compared. These are all based on the
negative regulator LacI, while positively regulated pro-
moters such as PBAD and Pm have not been used in such
comparative studies. The regulators of these two pro-
moters (AraC and XylS, respectively) are both members of
the same family of transcriptional activators [21]. The
AraC/PBAD system is quite extensively used and its charac-
teristics have been reviewed [1]. The XylS/Pm system was
included because it has several beneficial traits for protein
expression in general (reviewed by Brautaset et al. [21]),
and in combination with RK2 minimal replicons it has
been demonstrated to be capable of expressing proteins at
industrial levels in high cell density cultivations [14,22],
We have used this system extensively in our laboratory as
a model for studies of recombinant gene expression. Par-
ticular advantages of this system are that the levels of ex-
pression can be fine-tuned by various means [23-25], that
it is not host-dependent in contrast to most other systems
and that the inducer is cheap. Furthermore, expressionfrom the native system could be greatly improved by gen-
erating variants of the regulator protein XylS [26], the
DNA region corresponding to the Pm promoter region
[27] as well as the region corresponding to the Pm 50-
untranslated region (50-UTR) [28].
In this report we describe a systematic comparison of
both positively and negatively regulated expression sys-
tems. Being aware of the influence of the 50 end of the
coding region on expression [29,30], we intentionally
chose to use model genes with native 50 ends as opposed
to commonly used regions encoding N-terminal detec-
tion tags or solubility-enhancing fusion partners. The ex-
pression analyses were carried out at both the transcript
and the protein level (activity assays and total protein), and
we also included a flow cytometry based analysis of expres-
sion in individual cells. All comparisons were performed
using identical vector backbones, a procedure we believe
can be used generally as a diagnostic tool to identify bottle-
necks in recombinant protein production processes.
Results and discussion
Construction of a set of plasmids specifically designed for
comparative studies of commonly used expression
systems in E. coli
To reduce potential effects on expression unrelated to
the features of the regulator/promoter systems them-
selves all replicons used for comparisons were designed
in such a way that the backbones were identical and the
expression cassettes were in all cases integrated at the
same location (Figure 1 and Table 1). The selected sys-
tems include XylS/Pm (the native system; denoted in the
figures as M); the high level expression variant Pm ML1-
17 (abbreviated by M-1-17) [27]; LacI/PT7lac originating
from the pET vector series (Novagen; denoted as E);
the LacI/Ptrc system from the pTRC series of vectors
(Pharmacia; denoted as T); and finally the AraC/PBAD
system from the pBAD series of vectors (Invitrogen,
abbreviated by B). Further details related to transcrip-
tional start sites and 50-UTR regions are described in the
Methods section.
It is well known that gene dosage and expression levels
often correlate, at least to some extent. In order to in-
vestigate any potential gene-specific effects related to
this the cassettes were integrated into a mini-RK2 based
replicon (pSB-M1b, 5–7 copies per cell [33]), and the
pMB1 replicon (15–20 copies per cell [19], Novagen,
Invitrogen) used in commercially available vectors such
as pET and pBAD. In these two plasmid sets, genes cod-
ing for five different model proteins of varying biological
origins were placed under control of the five promoters
to cover a broad range of problems that may occur dur-
ing recombinant protein production (Table 2). Note also




























Figure 1 Illustration showing how the different constructs in
the study were generated based on pSB-M1b. The upper part
shows how the alternative regulator/promoter systems were
incorporated. pSB-M1b-1-17 contains a variant of the Pm core
promoter termed ML1-17 (see text). The lower part shows the oriV/
trfA region in pSB-M1b that was replaced with the pMB1 ori
described in Table 1.
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spective promoter-50-UTR regions on different 50 coding
sequences, as opposed to the study of Tegel et al. [20].
Specific gene sequence dependent parameters such as
mRNA secondary structures and the presence of rare
codons were taken into account by using optimized (for
E. coli) synthetic genes. The corresponding genes were
inserted into the two replicon types carrying the differ-
ent expression cassettes, (Table 1). Not only can expres-
sion be directly compared from different regulator/
promoter systems using these standardized vectors, but
they can also be used more generally as tools to identify
an appropriate expression system for the production of
any selected target protein.
Due to the nature of the expression systems it was ne-
cessary to use two different E. coli strains as hosts. Strain
ER2566 was chosen to compare expression from LacI/
PT7lac with XylS/Pm because it carries a chromosomal
copy of the T7 polymerase integrated into the lac op-
eron (NEB). Since the LacI/Ptrc system is also induced
by IPTG, it was decided to study expression in the same
host under the assumption that the expression of T7
polymerase does not affect expression from LacI/Ptrc
due to the specificity of this polymerase for its cognate
promoter [40]. Expression from XylS/Pm compared to
AraC/PBAD was performed in E. coli DH10B which is
unable to catabolize L-arabinose, the inducer of the
AraC/PBAD system.Protein production levels are generally stimulated by
increased gene dosage, but none of the tested cassettes
are superior for all genes
Three different genes, encoding luciferase, an antibody
fragment fused in frame to alkaline phosphatase (scFv173-
2-5-AP) and green fluorescent protein (GFP), respectively,
were selected as models in the initial study of the perfor-
mances of the various expression cassettes (Figure 2). The
alkaline phosphatase fusion protein is translocated to the
periplasm, while luciferase and GFP are cytoplasmic. The
results were monitored as activities, meaning that only
functional proteins were measured. The only parameter
that gave a consistent response for all systems was not sur-
prisingly gene dosage, as all cassettes gave rise to more ac-
tivity when they were utilized in a high plasmid copy
number context. However, the fold increase was heavily
protein and expression cassette dependent, ranging from
1.6 for GFP (Figure 2, Panel C) to 10.4 for the alkaline
phosphatase fusion in the LacI/PT7lac system (Figure 2,
Panel B). We also observed that cell growth was strongly
affected in several of the alkaline phosphatase fusion pro-
tein producing strains, and it was generally much more dif-
ficult to obtain reproducible data for this particular
protein. We believe the reason for this is that the export of
large amounts of protein is toxic to cell growth [41], in
some cases also in the uninduced state. This potential toxic
effect may even have resulted in accumulation of mutants
that grow faster than the originally inoculated strain due to
reduced scFv173-2-5-AP production. The maximal expres-
sion level is obviously very important in the context of re-
combinant protein production, and Figure 2 shows that in
this respect none of the systems is superior for all proteins.
Generally XylS/Pm ML1-17 and LacI/PT7lac tended to pro-
duce most recombinant protein in the studies in strain
ER2566 (Figure 2, Panels A-C). The mutations in the Pm
core region were of vital importance, as XylS/Pm ML1-17
produced between 1.2- and 4.0- fold more active protein
than the corresponding wild-type system. Note also that
AraC/PBAD generated similar amounts of active protein
compared to XylS/PmML1-17 when the studies were done
in an ara negative strain (DH10B; Figure 2, Panels D-F).
LacI/PT7lac is generally known to be a very strong system
because of the efficient transcription exerted by the T7
RNA polymerase [9,40], but the comparative analysis dem-
onstrated that this system was not superior to XylS/Pm
ML1-17 for the genes studied here. Especially in the higher
copy-number plasmids, up to four times more activity was
detected in strains harboring XylS/Pm ML1-17. We also
noted in this and other related ongoing studies in our la-
boratory that to get stable expression from the LacI/PT7lac
system, ER2566 cells needed to be freshly transformed
prior to expression studies, as also recommended by
Vethanayagam and Flower [42]. Similar observations were
not made for any of the other three systems.
Table 1 Plasmids used in this studya
Name Key features Source
pTA16/pSB-M1bb m-toluate- inducible Pm, xylS activator gene, RK2 replicon, bla reporter, Kanr [31]
pET16b IPTG-inducible PT7lac, lacI repressor gene, Amp
r Novagen
pBAD/gIII_calmodulin L-arabinose- inducible PBAD, araC activator gene, Amp
r Invitrogen
pTrc99A IPTG- inducible Ptrc promoter, lacI repressor gene, Amp
r Pharmacia
pIB11-lucS pIB11 [25] with lucS under control of xylS/Pm, Kan
r unpublished
pBAD24-GFP pBAD24 with gfpmut3 insert, Ampr [32]
pHOG-173-2-5-AP pHOG plasmid with scFv173-2-5-phoA fusion gene insert, provided by Affitech AS, Oslo, Ampr unpublished
pMA-GH pMA vector (GeneArtW, Invitrogen) with GH1S insert, provided by Vectron Biosolutions AS,
Trondheim, Ampr
unpublished
pMA-T-IL-1RA pMA vector (GeneArtW, Invitrogen) with IL1RNS insert, provided by Vectron Biosolutions AS,
Trondheim, Ampr
unpublished
pSB-P0x pSB-M1b variants with combinations of different features:
P. . . regulator/promoter system M. . . xylS/Pm
M-1-17. . . xylS/Pm variant ML1-17
E. . . lacI/PT7lac (from pET)
T. . . lacIq/Ptrc (from pTrc)
B. . . araC/PBAD (pBAD)
0. . . origin of replication 1. . . RK2 replicon
2. . . pMB1 replicon
x. . . reporter gene b. . . bla
l. . . lucS
s. . . scFv173-2-5-phoA
g. . . gfpmut3
h. . . GH1S
r. . . IL1RNS This study
e.g. pSB-M2l m-toluate- inducible Pm, xylS activator gene, pMB1 ori, lucS reporter, Kan
r This study
a bla: β- lactamase gene; lucS: synthetic luciferase gene; scFv173-2-5-phoA: single-chain antibody fragment 173-2-5 alkaline phosphatase fusion gene; gfpmut3:
gene for the optimized green fluorescent protein mutant 3; GH1S: synthetic gene for human growth hormone, IL1RNS: synthetic gene for human interleukin 1
receptor antagonist.
b pTA16 was named pSB-M1g in this study for consistency purposes.
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amounts of transcript and insoluble protein
In the analyses described above only active protein was
monitored, but potential big differences in target gene
transcript accumulation or inactive (insoluble) protein
production would not be discovered by such an analysis.Table 2 Properties of the proteins selected as expression rep
Protein Properties
Luciferase reporter protein, ~ 60.8 kDa, cytoplasmic local
detection via bioluminescence assay
scFv173-2-5-AP industrially relevant protein, ~77.2 kDa, fusion
through APa fusion, AP needs to be translocat
GFP reporter protein, ~ 26.9 kDa, cytoplasmic local
[35], very easy to detect by direct fluorometry
HGH industrially relevant protein, ~25.1 kDa, cytopla
IL-1RA industrially relevant protein, ~20.1 kDa, cytopla
aAlkaline phosphatase.We therefore investigated to what extent total protein
production is proportional to the amounts of transcript
produced, which is not necessarily the case [43-45]. For
this purpose, we included two additional proteins, the
medically relevant human growth hormone (HGH) and
interleukin-1RA (IL-1RA), see also (Table 2). Theorters
ization, generally low expression, rather easy to detect, very sensitive
protein, disulfide bonds, translocated to the periplasm, detectable
ed to be active [34]
ization, stable, known to be produced virtually only in its soluble form
smic localization, usually expressed in E. coli as soluble protein [36,37]
smic localization, usually expressed in E. coli as soluble protein [38,39]
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Figure 2 Maximum expression of three different genes placed under control of different regulator/promoter systems. Data represent
relative expression levels under induced conditions where the activity of M1x (gene x under conrol of the Pm wildtype promoter, RK2 replicon)
was set to 1.0. Expression was induced in a way that activity levels were maximized: 2 mM m-toluate for strains harboring XylS/Pm- based
constructs, 1 mM IPTG for those with LacI/PT7lac, 0.2 mM IPTG for LacI/Ptrc and 0.015% L-arabinose for AraC/PBAD. The following E. coli strains
were used as expression hosts. Panels A-C: ER2566. Panels D-F: DH10B. The naming code is the following: The capital letter represents the
regulator/promoter system and the digit represents the origin of replication; for details see Table 1. The data presented are from independent
biological replica.
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plasmids with the pMB1 replicon, which as described
above generally led to a higher level of protein production
(measured as activity). One general conclusion following
from these experiments was that the LacI/PT7lac system
generated much more transcript than XylS/Pm (between
6.2 and 20 times more) and LacI/Ptrc (between 3.9 and
206 times more) for all the five tested genes. XylS/Pm
ML1-17 generated more transcript than LacI/Ptrc as well
(Figure 3), ranging from 3.3 times for lucS mRNA and 88
times for GH1S mRNA, except for the special case with
scFv173-2-5-phoA. Studies of AraC/PBAD was not included
here since it required another host (DH10B) and since
initial experiments indicated that this system (in contrast
to T7) behaved very similar to XylS/Pm in the sense that
transcript and protein amounts correlated well. At the
total protein production level the analysis revealed more
protein-specific effects compared to in the functional
studies (Figure 2). In case of luciferase the amount of
active protein was highest for XylS/Pm ML1-17 both
according to activity measurements (see above) and
deduced as soluble protein (Figure 3, Panel A). However,
the very high level of transcription in the LacI/PT7lac
system resulted in a correspondingly big production ofinsoluble and inactive luciferase protein, not seen to a
comparable extent for any of the other systems.
For GFP and HGH (Panels C and D) production of sol-
uble protein was very effective in both XylS/Pm ML1-17
and LacI/PT7lac, and the final outcome at the protein level
was more similar for these proteins than for luciferase.
Generally, LacI/PT7lac had an apparent advantage by its
performance at the transcriptional level, but this potential
was often not reflected at the translational level, such that
the system often produced a vast amount of transcripts
that were either translated into inactive protein or were
not translated at all. Note also that the amounts of protein
and transcript correlated well for XylS/Pm and XylS/Pm
ML1-17 (except for scFv173-2-5-AP, Panel B), probably
mainly because the amounts of transcript were generally
much lower than for LacI/PT7lac and therefore did not
overload the translational machinery. It is also interesting
to note that, in terms of both active and total protein
produced, XylS/Pm ML1-17 and LacI/PT7lac generally
performed best. For scFv173-2-5-AP (Figure 3, Panel B) a
more complex picture was observed, but this could be
mainly related to the effects of toxic protein production
on host growth or variability among the systems in the
kinetics of induction [46].





































































































M E T TEM71-1-M.gen neg. M-1-17
M E Tneg. M-1-17 M E Tneg. M-1-17
Figure 3 Correlation between the accumulated transcript and protein produced after induction. The five proteins (Panels A-E) were
expressed in E. coli ER2566 harboring pMB1-based plasmids. Five hours after induction, samples were collected for relative quantification real-time
RT-PCR (qRT-PCR) and SDS-PAGE. Accumulated transcript data were correlated to the XylS/Pm system (M2x; gene x under conrol of the Pm
wildtype promoter, pMB1 replicon). The total protein fractions were separated into the soluble supernatant and the insoluble pellet fraction after
sonication and separated through SDS-PAGE followed by staining with Coomassie Brilliant blue. Further information about the naming system
can be found in Table 1. Neg: Negative control.
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lowest for AraC/PBAD
The tightness of the different regulator/promoter sys-
tems is another important feature, particularly for pro-
duction of host-toxic proteins [47]. We studied this with
the same set-up as for induced conditions, using lucifer-
ase, scFv173-2-5-AP and GFP, and as expected the back-
ground increased for all systems when the higher copy
number vectors were used. The increase was in most
cases approximately proportional to that of the plasmid
copy number. Therefore, only findings collected from
strains harboring pMB1-based plasmids are presented
(Figure 4).
Generally, LacI/Ptrc tended to be the leakiest system
producing 3.8 to 8.2 times more active protein than XylS/
Pm under uninduced conditions. Similarly, XylS/Pm
ML1-17 displayed 2.8- to 5.8-fold higher background ex-
pression than the wild-type system. AraC/PBAD appeared
to be, as expected, the tightest system giving rise to 0.1
and 0.4 times the background level for luciferase and
scFv173-2-5-AP, respectively. LacI/PT7lac was also quitetightly regulated although it generated the highest back-
ground expression for GFP (Figure 4, Panel C).
The ratio between the induced and the uninduced ex-
pression levels was protein dependent with relatively small
induction windows for svFv173-2-5-AP (1.2-25) and large
for luciferase (60–3,000). In strain ER2566, XylS/Pm and
LacI/PT7lac displayed the highest induction windows, while
LacI/Ptrc was by far the least inducible system (0.1-0.2
times compared to XylS/Pm). In DH10B, induction ratios
for AraC/PBAD were 1.3-27 times higher than the ratios of
XylS/Pm and XylS/Pm ML1-17. These results are consist-
ent with a previous report documenting that the induction
ratio in the AraC/PBAD system can reach up to 1,200-fold
when functionally compared for the phoA reporter gene
[11]. As for XylS/Pm [24,25], the induction level can also
be modulated over a wide concentration range by varying
the inducer concentration. In addition, uninduced levels
can be even further reduced by the presence of glucose,
which represses the expression in this system [47]. The
main disadvantage of the AraC/PBAD system is that the
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M E T TEM71-1-M TEM71-1-M M-1-17
M B BM71-1-M M-1-17
E
Figure 4 Investigation of the tightness of different regulator/promoter systems in combination with the pMB1 replicon. Protein activity
was determined in parallel with induced cultures at the time point corresponding to five hours after induction. The data presented are from
independet biological replica. The following E. coli strains were used as expression hosts. Panels A-C: ER2566. Panels D-E: DH10B. The capital
letters represent the regulator/ promoter systems according to Table 1. Uninduced expression of GFP in DH10B was very close to the detection
limit in LB medium and was left out.
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binding sites vary over a wide range
The DNA region corresponding to the 50-UTR plays a
central role in regulation of gene expression [48-50]. It
covers the untranslated nucleotides at the 50 end of the
mRNA [51,52], including the ribosome binding site
(RBS) that together with the translational start site influ-
ence expression [28,49,53]. One program frequently used
to analyse the expected efficiency of these nucleotide se-
quences is the RBS calculator [54]. We applied its re-
verse engineering function on the various 50-UTR-gene
combinations used in the study and determined the
translation initiation rate (TIR) values of the respective
expression systems. The most striking finding was that
the relative differences between the calculated TIRs of
the four cognate RBSs were rather similar for all the five
genes studied (Figure 5), although there were exceptions
(see LacI/PT7lac for HGH and AraC/PBAD for IL-1RA).
Generally, the calculator predicted that the TIR values of
the LacI/PT7lac and the AraC/PBAD RBSs were higher
than those of XylS/Pm and LacI/Ptrc RBSs, suggesting a
more efficient translation. The relative differences be-
tween the TIRs of the LacI/Ptrc and XylS/Pm RBSs
depended on the coding sequence.
To correlate the calculated TIR values with our experi-
mental data is not straight forward because the totalprotein levels are obviously also dependent on the effi-
ciencies of the promoter sequences, which are not a part
of the calculation of the TIR values. However, by com-
paring both transcript and protein amounts available
from the data presented in Figure 3 such effects can at
least partly be taken into account. The amounts of accu-
mulated transcripts derived from LacI/PT7lac were gener-
ally highest and combined with a predicted more
efficient TIR one might expect that this system would
come out best at the protein level in all cases. However,
this prediction was only in agreement with the luciferase
data, and with the ScFv-173-2-5-AP and IL-1RA data to
a more limited extent. In contrast, for GFP and HGH
the experimental data did not support the prediction. It
should also be remembered that efficient translation in
itself may contribute to more accumulated transcript
due to translation-mediated transcript stabilization
[55,56]. For XylS/Pm ML1-17 there appeared to be more
protein per transcript compared to LacI/PT7lac and the
total amounts of protein were at least equally good for
this system, presumably indicating a better balance be-
tween the capacities of the transcriptional and transla-
tional systems. For LacI/Ptrc the calculator correctly
predicted a very poor expression of HGH.
In general, it is possible to some extent to use the RBS
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Figure 5 Theoretical analysis of the translational start site by calculating the translation initiation rate (TIR). The complete 50-UTR
sequences in combination with the first 50 nucleotides of the respective genes (lucS (Panel A), scFv173-2-5-phoA (B), gfpmut3 (C), GH1S (D) and IL1RNS
(E)) were used as input sequences for the RBS calculator [54].
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just one among several parameters that affect the final
protein production level. We have analyzed the previ-
ously reported very efficient UTR variants obtained by
screening [28]. Despite the great stimulatory effect of
these screened UTRs on protein expression (up to 20-
fold), the calculator only predicted minor improvements
relative to the wild-type sequence (between 1.5 and 3.6
times for the best variants).
Flow cytometry analysis of GFP expression in individual
cells revealed significant differences among the various
regulator/promoter systems
Analyses of recombinant protein expression are mostly
carried out at the level of cell populations, potentially
masking significant differences in the level of expressed
proteins between individual cells, which are known to
occur [57,58]. If such heterogeneity exists it may repre-
sent another possibility for system improvement, e.g. by
finding ways to reduce the fraction of cells with low ex-
pression level. This is also relevant in metabolic engin-
eering projects involving metabolite flux control in
biochemical pathways [59].
To analyze the level of homogeneity we used flow cy-
tometry to quantitate GFP as it can be easily detected
and because it was shown to be produced at high levels
from the regulator/promoter systems used in this work,
thus representing a relevant example in recombinant
protein production. The fluorescence level, which re-
flects the number of GFP molecules, among the majority
of cells harvested at a given time point typically variedin a 5–10 fold range (Figure 6). In most cases, the fluor-
escence values fell within a signal peak, which moved to
higher intensities with extended time after induction, as
expected. The highest production levels were found in
cells expressing GFP from XylS/Pm ML1-17, LacI/PT7lac
and AraC/PBAD (where a different host strain was used),
also consistent with what was observed at the population
level. However, the analysis also revealed several new ob-
servations. For the two XylS/Pm-based systems the dis-
tributions were broader for the wild-type system
(Figure 6, Panel A) than for XylS/Pm ML1-17 (Figure 6,
Panel B), meaning that the promoter mutations im-
proved culture homogeneity. The reasons for this are
not clear but they might be related to differences in the
efficiency of transcription initiation. Fluorescence distri-
butions of cells expressing GFP from LacI/PT7lac
(Figure 6, Panel C) were quite unique compared to those
from the other systems. The expression profile at the
time of induction is surprisingly broad in this system
compared to the profiles of the remaining systems, pos-
sibly indicating low and varying (between individual
cells) levels of T7 RNA polymerase production. Sec-
ondly, from two hours post induction onwards, two
peaks became visible, one at rather low and one at rather
high fluorescence values. The peak heights were also
strongly reduced at the end. Most probably, the peak
around lower fluorescence values late after induction re-
flects the formation of two subpopulations of cells as de-
scribed by Zhao et al. [60], one being soluble GFP
bearing and the other being dominated by inclusion














































































































Time [min] 0       20      180     300
Mean 0.32   2.68    49.5    56.1
Spread [CV] 65.6   92.2     63.4   69.9
Time [min] 0       20      180     300
Mean 6.51   17.6    135     153
Spread [CV]   83.5   48.0    47.0    48.2
Time [min] 0       20      180     300
Mean 10.9    19.6    216     254 
Spread [CV]  150     72.7    60.9    96.0
Time [min] 0       20      180     300
Mean 1.55   11.9    33.7    33.5
Spread [CV]   46.7   47.0    44.0    42.0
0.1 1 10 100 1000
BE
Fluorescence [au]
Time [min] 0       20      180     300
Mean 0.13   1.01    112     128
Spread [CV]   54.5   175     47.1    59.5
Time after
induction
Figure 6 Analysis of the distribution of expression using flow cytometry. Strains were grown under standard conditions. At the time point
of induction (t= 0 min) and at several points afterwards (t= 20–300 min), samples were collected, snap-frozen, and collectively analyzed with a
flow cytometer. The spread is represented by the coefficient of variation (CV). Panels A-D: ER2566, Panel E: DH10B.
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vector context [4].
The LacI/Ptrc system (Figure 6, Panel D) is character-
ized by a very even signal distribution throughout the
entire induction period. Interestingly, the mean fluores-
cence remained constant already two hours after induc-
tion, possibly a consequence of a very fast activation of
transcription after inducer addition in this system.
The AraC/PBAD system, displayed a similar behaviour
as XylS/Pm meaning that it takes an extended time until
all cells are induced as reflected by a tail of the distribu-
tion towards low fluorescence values (Figure 6, Panel E).
One hour after induction, the distribution fell into a sin-
gle, rather narrow peak that was shifted towards higher
fluorescence values over time.
The outcomes of the flow cytometry experiments
showed that there is a quite big variation in GFP expres-
sion level among individual cells. By better understanding
the factors controlling this variability it may become pos-
sible to improve expression at the population level. This
conclusion is supported by the observation mutations in
the Pm promoter region lead to more homogeneity.
Conclusions
Development of efficient recombinant gene expression pro-
tocols is often based a lot on case-specific trial and error
approaches, and the results reported here contribute to theunderstanding of why. We have summarized the various
observations (Table 3), and the LacI/PT7lac system can be
distinguished from all the other systems by its general tends
to give rise to more transcript than all the other systems.
The difference relative to the XylS/Pm system may be
reduced or eliminated by incorporating more mutated
control elements, but at the moment this would lead to
very high levels of protein synthesis also in the absence of
inducer [31]. Since we have shown before that even the
wild-type XylS/Pm system can in some cases generate pro-
tein production at industrial levels it is clear that LacI/PT7lac
will only have an important advantage in those cases where
the amount of transcript is the bottleneck. The experiments
with GFP, HGH and IL-1RA illustrate cases where this has
limited or no relevance (compared to XylS/Pm ML1-17). In
contrast, for luciferase the amounts of transcript appears to
be very important, but the potential in the LacI/PT7lac
system is in this case lost by the excessive production of
inactive protein. LacI/Ptrc generally has the advantage (for
applications where this might be relevant) of a fast onset of
protein production and a homogenous expression profile.
However, both high levels of expression in the absence of
inducer and comparatively low total production make it the
least desirable if one is aiming at highest possible level of
expression. AraC/PBAD seems to be best with respect to
tight regulation of the uninduced state coupled with high
expression when induced. The XylS/Pm system has a big
Table 3 Summary of the findings derived from the comparative expression study
Category Regulator/promoter system References
XylS/Pm and Pm ML1-17 LacI/PT7lac LacI/Ptrc AraC/PBAD
Components XylS regulator LacI regulator LacI regulator AraC regulator
Pm promoter (native or
variant)
T7lac promoter trp/lac hybrid promoter PBAD promoter
CAP binding site CAP binding site





Medium requirements none (glucose)b none (glucose)b [3,10,11,42]
Range of inducer 0.001 - 2.0 mM 0.05 - 2.0 mM 0.05 - 2.0 mM 0.001% - 1% [1,25]
Expression level low - high intermediate - high low - intermediate intermediate - high This study
Basal expression low - high low - high High low This study
Induction ratio intermediate intermediate-high Low high This study
Accumulated transcript low - intermediate high below detection -
intermediate
intermediate This study





mixed populations This study
Recommended
applications










a Expression of lysozyme, the natural inhibitor of T7 RNA polymerase, reduces the basal transcription from PT7lac.
b Supplementing glucose leads to catabolite repression which reduces basal transcription levels.
c Limited suitability. See ‘Results and discussion’ section for detailed information.
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probably easiest to adapt to new bacterial hosts for cases
where E. coli cannot be developed to perform in a satisfac-
tory way. In summary we believe that the vectors developed
for this study can be used as an efficient early test system
for new proteins, perhaps by using XylS/Pm ML1-17, LacI/
PT7lac and AraC/PBAD. The outcome of such a simple first
experiment will probably often lead to an identification of
the nature of the main bottleneck for this particular case,
shortening the time from testing to development of a good
production process. The further studies would involve a
detailed analysis of parameters such as growth media
composition, culture incubation temperature and host
strain, which are known to affect recombinant protein
expression at various levels.
Methods
Strains, standard DNA manipulations and growth
conditions
E. coli DH5α (Bethesda Research Laboratories) was used
for plasmid propagation during cloning steps. Recom-
binant DH5α strains were grown at 37°C in liquid Luria
Bertani (LB) broth or on solid LB plates with appropriateantibiotics (kanamycin 50 μg/mL; ampicillin 200 μg/
mL). E. coli ER2566 (New England Biolabs, NEB) and E.
coli DH10B (Invitrogen) served as expression hosts dur-
ing the comparative studies. In comparison to the com-
monly used strain E. coli BL21(DE3), the former strain
offers higher transformation efficiency for toxic clones
and less background expression (NEB). All DNA manip-
ulations were carried out according to standard proce-
dures [61] or according to manufacturers’ instructions.
PCR was performed using the Expand High Fidelity PCR
systems kit (Roche), and essential regions in PCR prod-
ucts were verified by sequencing. Functionality of the
regulator/promoter systems was confirmed using bla as
reporter gene determining the levels of resistance to
ampicillin as described previously [62].
Vector constructions
PCR primers used during various cloning steps are listed
in Table 4. Plasmids used as templates or constructs that
were generated in this study are listed in Table 1.
Construction of pSB-M2b: The region of pBAD_gIII_
calmodulin containing the origin of replication from
pMB1 was PCR amplified using primer pair Pwitw6_badF
Table 4 Oligonucleotides used in this study
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Pwitw5_SpeI was used to amplify pSB-M1b [31] excluding
the RK2 ori (trfA coding region and the oriV origin of
replication). After digestion with AscI and SpeI of both
the amplified pMB1 ori and the pSB-M1b -resulting PCR
product, the two fragments were ligated to each other
resulting in plasmid pSB-M2b. The difference between
copy-numbers of RK2- and pMB1-based plasmids was
confirmed by agarose gel electrophoresis. Construction of
pSB-P0b introducing different regulator/promoter sys-
tems: Three different regulator/promoter systems were
chosen to substitute the region spanning xylS/Pm in pSB-
M1b and pSB-M2b. The lacI/PT7lac region was amplified
from pET16b using ET_AgeI_fwd and ET_NdeI_rev and
inserted into the two depicted backbones using NdeI and
AgeI, generating pSB-E1b and pSB-E2b. The lacIq/Ptrc
region was amplified from pTrc99A using TRC_AgeI_
fwd1and TRC_NdeI_rev1 prior to insertion into pSB-M1band pSB-M2b using AgeI and NdeI, generating pSB-T1b
and pSB-T2b. Finally, the PCR product covering the
araC/PBAD region from pBAD/gIII_calmodulin generated
with the primers BAD_BbsI_fwd and BAD_NdeI_rev was
inserted into the above mentioned backbones using BbsI
and NdeI, creating pSB-B1b and pSB-B2b. In order to in-
sert the Pm variant ML1-17 [27], pSB-M1b and pSB-M2b
were digested with XbaI and PciI removing the Pm core
promoter region which was replaced by two annealed
oligonucleotides that constitute the double-stranded Pm
ML1-17 fragment with XbaI and PciI compatible ends,
creating pSB-M1b-1-17 and pSB-M2b-1-17. Introduction
of other genes of interest: All pSB-P0b variants, except for
pSB-B2b, were digested with NdeI and BamHI to excise
the bla gene and to insert the lucS gene from pIB11-lucS
instead, generating pSB-P0l variants. pSB-B2b and pSB-
M1l were digested with NdeI and KpnI. The resulting
DNA fragment corresponding to the pSB-B2 backbone
and the lucS gene were ligated to each other to generate
pSB-B2l. The scFv173-2-5-phoA gene was PCR cloned
from pHOG-173-2-5-AP with primer pair pelB_fwd and
APhis_rev2. The enzyme combination NdeI and BamHI
was used to replace the bla gene from pSB-M1b with
the digested scFv173-2-5-phoA PCR product resulting in
pSB-M1s. From there on NdeI and BamHI were used to
generate all pSB-P0s variants, except for pSB-B2s. This
construct was generated by digesting pSB-B2b and pSB-
B1s with BamHI and ligating the pSB-B2 backbone with
the scFv173-2-5-phoA BamHI digested insert from pSB-
B1s. gfpmut3 originating from pBAD24-GFP was inserted
into the pSB-P0b variants using NdeI and BamHI with the
exception of pSB-B2b. Instead, BamHI was used to excise
the gene from pSB-B1g and to place it into pSB-B2 back-
bone (originating from pSB-B2l) to generate pSB-B2g.
Genes GH1S and IL1RNS were excised from pMA-GH
and pMA-T-IL-1RA with NdeI and BamHI and trans-
ferred to the pSB-P0b variants with the Pm, Pm ML1-17,
PT7lac and Ptrc promoter using the same enzymes,
resulting in pSB-P0h and pSB-P0r variants.
Growth conditions for comparative expression studies
The general cultivation protocol was based on recom-
mendations published by the European Molecular Biol-
ogy Laboratory (EMBL) [63]. For E. coli cultivations LB
medium was chosen because it is widely used among
molecular biologists and at the same time it was avoided
to use media with glucose as a carbon source due to the
influence of glucose on background expression from PT7lac
and PBAD through catabolite repression [64]. A growth
temperature of 30°C was applied for slowing down the
growth rate of E. coli, as this generally leads to more sol-
uble protein [65]. Initially the kinetics of protein accumu-
lation was studied for all expression cassettes, using GFP
(fluorescence) and luciferase (activity) as the main models.
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post induction were varied and we found that five hours
induction was sufficient to reach a plateau of accumulated
protein per OD unit of cells. For GFP the accumulation
rate was nearly constant (slightly lower from 3–5 hours)
over this time-period. For most of the proteins it was
complicated to follow the kinetics accurately since there
was no quantitative method for measurement available,
and in case of luciferase activity measurements may not
necessarily correlate exactly with the accumulation kinet-
ics of the insoluble fraction.
Recombinant E. coli ER2566 and DH10B strains were
grown in 2 ml LB supplemented with 50 μg/ml kanamycin
at 30°C over-night. Then 15 ml of LB with kanamycin in
shake flasks were inoculated with the overnight culture to
an initial OD600 of 0.05. Following incubation at 200 rpm
and 30°C expression was induced at OD600= 0.5-0.6 as fol-
lows: 2 mM m-toluate for strains harboring Pm- based
constructs, 1 mM IPTG for those with PT7lac, 0.2 mM
IPTG for Ptrc and 0.015% L-arabinose for PBAD. Growth
was continued for 5 more hours at 30°C.Transcript analysis by qRT-PCR
At harvest, 0.5 ml of culture was stabilized with RNA pro-
tect (Qiagen) prior to freezing. The subsequent total RNA
isolation, cDNA synthesis and relative transcript quantifi-
cation by qRT-PCR was performed as described previously
[28]. Primer pairs used during amplification are listed in
Table 4. Transcript generated from the 16S rRNA gene
was used for normalization.Activity measurements of the different reporters
The luciferase assay was performed using the Luciferase
assay System (Promega). At harvest, the cell culture was
normalized to an OD600 of 0.5. 90 μL of this mixture was
supplemented with 10 μL of K2HPO4, pH 7.8, 20 mM
EDTA prior to lysis with the Luciferase Cell Culture Lysis
Reagent (CCLR, Promega). The remaining steps of the
protocol were carried out according to the manufac-
turer’s instructions except that the luciferase activities
were determined from 10 μL lysed culture mixed with
50 μL of substrate. The alkaline phosphatase assay
was performed as described previously [66]. Fluore-
scence measurements of strains expressing GFP were
performed with the FLUOstar Omega instrument
(BMG Labtech) together with the corresponding
Omega Software. Fluorescence intensity was deter-
mined directly from the cultures using an appropriate
filter set (excitation: 485 nm; emission: 520 nm).
Values were normalized against the optical density.
Data were acquired from three biological and thereof
three technical replica.Protein analysis by SDS-PAGE
For SDS-PAGE analysis 50 ml culture volume was used.
Because of impaired growth of recombinant strains ex-
pressing scFv173-2-5-AP, 3xLB was used to get sufficient
cell mass for analysis. The general growth conditions
were as described above for the comparative expression
studies. At harvest, bacterial pellets were washed with
0.9% NaCl and 100 mg pellet (wet weight) was frozen
until further processing. Pellets were resuspended in
lysis buffer (50 mM Tris–HCl, pH 8.0, 1 mM EDTA,
100 mM NaCl, 8 mM MgCl2). The solution was soni-
cated using a Branson Sonifier DSM tip (sonication for
3.5 minutes on ice, duty cycle 35% and output control
3.0). Soluble and insoluble fractions were separated by
centrifugation and treated with 62.5 U/ml Benzonase nu-
clease (Merck). Protein gels were run under denaturing
conditions using ClearPAGE 10% gels and ClearPAGE
SDS-R Run buffer (C.B.S. Scientific) followed by staining
with Coomassie Brilliant blue R-250 (Merck).
Flow-cytometry
Cultures were grown essentially as decribed for SDS-
PAGE analysis. At various time points after induction, 1
ml of culture was collected, supplemented with glycerol to
10% and snap-frozen in liquid nitrogen until further ana-
lysis. For single-cell fluorescence measurements, samples
were thawed on ice and diluted in PBS. Flow cytometry
was performed using the CyFlowW Space flow cytometer
(Partec) equipped with a 488 nm blue solid state laser
(200 mW) and a 536/ 40 nm band pass filter. For each
sample, 150,000 events were collected at a rate between
800 and 2,000 events per second. Data were analysed
with the Windows™ XP FloMax(R) software (Quantum
Analysis). The mean and spread (coefficient of variation
(CV)) of the distributions were calculated over all collected
values after gating.
Abbreviations
50-UTR: 50-untranslated region; qRT-PCR: Relative quantification real-time RT-
PCR; scFv173-2-5-AP: Single-chain antibody fragment 173-2-5 alkaline
phosphatase fusion protein; GFP: Green fluorescent protein; HGH: Human
growth hormone; IL-1RA: Human interleukin 1 receptor antagonist;
EMBL: European Molecular Biology Laboratory; SDS-PAGE: Sodium dodecyl
sulfate- polyacrylamide gel electrophoresis; RBS: Ribosome binding site;
TIR: Translation initiation rate; CV: Coefficient of variation; LB: Luria Bertani;
NEB: New England Biolabs; IPTG: Isopropyl β-D-1-thiogalactopyranoside.
Competing interests
The authors declare no competing interests.
Authors’ contributions
SB prepared all genetic constructs and strains, performed all experimental
work on luciferase, GFP and HGH, participated in the design of the study
and wrote the paper. VK performed the experimental work on scFv173-2-5-
AP and IL-1RA and assisted in editing the paper. JM performed the analysis
of the flow cytometry data. RL and SV conceived of the study. In addition, SV
and TB participated in its design, coordinated the work and critically edited
the paper. All authors read and approved the final manuscript.
Balzer et al. Microbial Cell Factories 2013, 12:26 Page 13 of 14
http://www.microbialcellfactories.com/content/12/1/26Acknowledgements
We a very grateful to Laila Berg for the gift of pIB11-lucS, Affitech, AS, Oslo
for providing pHOG-173-2-5-AP and Vectron Biosolutions AS, Trondheim, for
the gift of pMA-GH and pMA-T-IL-1RA. We thank Andrea Ebert for assisting
with the collection of the flow cytometry data. This work was funded by a
stipend that SB obtained from the Faculty of Natural Sciences and
Technology, NTNU, Trondheim.
Author details
1Department of Biotechnology, NTNU, Sem Sælands vei 6, Trondheim 7491,
Norway. 2Faculty of Physics and CeNS, LMU Munich, Munich 80539,
Germany. 3Department of Biotechnology, SINTEF Materials and Chemistry,
Trondheim 7465, Norway.
Received: 9 November 2012 Accepted: 1 March 2013
Published: 18 March 2013
References
1. Terpe K: Overview of bacterial expression systems for heterologous
protein production: from molecular and biochemical fundamentals to
commercial systems. Appl Microbiol Biotechnol 2006, 72(2):211–222.
2. Lee SK, Keasling JD: A propionate-inducible expression system for enteric
bacteria. Appl Environ Microbiol 2005, 71(11):6856–6862.
3. Blatny JM, Brautaset T, Winther-Larsen HC, Haugan K, Valla S: Construction and
use of a versatile set of broad-host-range cloning and expression vectors
based on the RK2 replicon. Appl Environ Microbiol 1997, 63(2):370–379.
4. Choi YJ, Morel L, Le François T, Bourque D, Bourget L, Groleau D, Massie B,
Míguez CB: Novel, versatile, and tightly regulated expression system for
Escherichia coli strains. Appl Environ Microbiol 2010, 76(15):5058–5066.
5. Menzella HG, Gramajo HC: Recombinant protein production in high cell
density cultures of Escherichia coli with galactose as a gratuitous
inducer. Biotechnol Prog 2004, 20(4):1263–1266.
6. Makart S, Heinemann M, Panke S: Characterization of the AlkS/PalkB-
expression system as an efficient tool for the production of recombinant
proteins in Escherichia coli fed-batch fermentations. Biotechnol Bioeng
2007, 96(2):326–336.
7. Giacalone MJ, Gentile AM, Lovitt BT, Berkley NL, Gunderson CW, Surber MW:
Toxic protein expression in Escherichia coli using a rhamnose-based
tightly regulated and tunable promoter system. Biotechniques 2006,
40(3):355–364.
8. Wu H, Pei J, Jiang Y, Song X, Shao W: pHsh vectors, a novel expression
system of Escherichia coli for the large-scale production of recombinant
enzymes. Biotechnol Lett 2010, 32(6):795–801.
9. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW: Use of T7 RNA
polymerase to direct expression of cloned genes. Methods Enzymol 1990,
185:60–89.
10. Amann E, Ochs B, Abel KJ: Tightly regulated tac promoter vectors useful
for the expression of unfused and fused proteins in Escherichia coli.
Gene 1988, 69(2):301–315.
11. Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation,
and high-level expression by vectors containing the arabinose PBAD
promoter. J Bacteriol 1995, 177(14):4121–4130.
12. Schofield DA, Westwater C, Dolan JW, Norris JS, Schmidt MG: Tight
regulation and modulation via a C1-regulated promoter in Escherichia
coli and Pseudomonas aeruginosa. Curr Microbiol 2002, 44(6):425–430.
13. Woestenenk EA, Hammarström M, van den Berg S, Härd T, Berglund H: His
tag effect on solubility of human proteins produced in Escherichia coli: a
comparison between four expression vectors. J Struct Funct Genomics
2004, 5(3):217–229.
14. Sletta H, Tøndervik A, Hakvåg S, Aune TE, Nedal A, Aune R, Evensen G, Valla
S, Ellingsen TE, Brautaset T: The presence of N-terminal secretion signal
sequences leads to strong stimulation of the total expression levels of
three tested medically important proteins during high-cell-density
cultivations of Escherichia coli. Appl Environ Microbiol 2007, 73(3):906–912.
15. Carrier T, Jones KL, Keasling JD: mRNA stability and plasmid copy number
effects on gene expression from an inducible promoter system.
Biotechnol Bioeng 1998, 59(6):666–672.
16. Wong Ng J, Chatenay D, Robert J: Plasmid copy number noise in
monoclonal populations of bacteria. Phys Rev E 2010, 81(1):8.
17. Glick BR: Metabolic load and heterologous gene expression. Biotechnol
Adv 1995, 13(2):247–261.18. Makrides SC: Strategies for achieving high-level expression of genes in
Escherichia coli. Microbiol Rev 1996, 60(3):512–538.
19. Sørensen HP, Mortensen KK: Advanced genetic strategies for recombinant
protein expression in Escherichia coli. J Biotechnol 2005, 115(2):113–128.
20. Tegel H, Ottosson J, Hober S: Enhancing the protein production levels in
Escherichia coli with a strong promoter. FEBS J 2011, 278(5):729–739.
21. Brautaset T, Lale R, Valla S: Positively regulated bacterial expression
systems. Microb Biotechnol 2009, 2(1):15–30.
22. Sletta H, Nedal A, Aune TE, Hellebust H, Hakvåg S, Aune R, Ellingsen TE,
Valla S, Brautaset T: Broad-host-range plasmid pJB658 can be used for
industrial-level production of a secreted host-toxic single-chain antibody
fragment in Escherichia coli. Appl Environ Microbiol 2004, 70(12):7033–7039.
23. Blatny JM, Brautaset T, Winther-Larsen HC, Karunakaran P, Valla S: Improved
broad-host-range RK2 vectors useful for high and low regulated gene
expression levels in gram-negative bacteria. Plasmid 1997, 38(1):35–51.
24. Winther-Larsen HC, Josefsen KD, Brautaset T, Valla S: Parameters affecting
gene expression from the Pm promoter in gram-negative bacteria.
Metab Eng 2000, 2(2):79–91.
25. Lale R, Berg L, Stüttgen F, Netzer R, Stafsnes M, Brautaset T, Vee Aune TE,
Valla S: Continuous control of the flow in biochemical pathways through
5´ untranslated region sequence modifications in mRNA expressed from
the broad-host-range promoter Pm. Appl Environ Microbiol 2011,
77(8):2648–2655.
26. Vee Aune TE, Bakke I, Drabløs F, Lale R, Brautaset T, Valla S: Directed
evolution of the transcription factor XylS for development of improved
expression systems. Microb Biotechnol 2009, 3(1):38–47.
27. Bakke I, Berg L, Aune TE, Brautaset T, Sletta H, Tøndervik A, Valla S: Random
mutagenesis of the Pm promoter as a powerful strategy for
improvement of recombinant gene expression. Appl Environ Microbiol
2009, 75(7):2002–2011.
28. Berg L, Lale R, Bakke I, Burroughs N, Valla S: The expression of recombinant
genes in Escherichia coli can be strongly stimulated at the transcript
production level by mutating the DNA-region corresponding to the
5'-untranslated part of mRNA. Microb Biotechnol 2009, 2(3):379–389.
29. Tuller T, Waldman YY, Kupiec M, Ruppin E: Translation efficiency is
determined by both codon bias and folding energy. Proc Natl Acad Sci
USA 2010, 107(8):3645–3650.
30. Loh E, Memarpour F, Vaitkevicius K, Kallipolitis BH, Johansson J, Sondén B:
An unstructured 5´-coding region of the prfA mRNA is required for
efficient translation. Nucl Acids Res 2012, 40(4):1818–1827.
31. Zwick F, Lale R, Valla S: Strong stimulation of recombinant protein
production in Escherichia coli by combining stimulatory control elements
in the expression cassette. Microb Cell Fact 2012, 11(1):133.
32. Megerle JA, Fritz G, Gerland U, Jung K, Rädler JO: Timing and dynamics of
single cell gene expression in the arabinose utilization system. Biophys J
2008, 95(4):2103–2115.
33. Figurski DH, Meyer RJ, Helinski DR: Suppression of ColE1 replication
properties by the Inc P-1 plasmid RK2 in hybrid plasmids constructed
in vitro. J Mol Biol 1979, 133(3):295–318.
34. Hoffman CS, Wright A: Fusions of secreted proteins to alkaline
phosphatase: an approach for studying protein secretion. Proc Natl Acad
Sci USA 1985, 82(15):5107–5111.
35. Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green
fluorescent protein (GFP). Gene 1996, 173(1 Spec No):33–38.
36. Shin NK, Kim DY, Shin CS, Hong MS, Lee J, Shin HC: High-level production
of human growth hormone in Escherichia coli by a simple recombinant
process. J Biotechnol 1998, 62(2):143–151.
37. Goeddel DV, Heyneker HL, Hozumi T, Arentzen R, Itakura K, Yansura DG,
Ross MJ, Miozzari G, Crea R, Seeburg PH: Direct expression in Escherichia
coli of a DNA sequence coding for human growth hormone. Nature 1979,
281(5732):544–548.
38. Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A,
Bowlin TL, Yanofsky S, Barrett RW: Refined crystal structure of the
interleukin-1 receptor antagonist- Presence of a disulfide link and a
cis-proline. Eur J Biochem 1995, 227(3):838–847.
39. Steinkasserer A, Solari R, Mott HR, Aplin RT, Robinson CC, Willis AC, Sim RB:
Human interleukin-1 receptor antagonist- High yield expression in E. coli
and examination of cysteine residues. FEBS Lett 1992, 310(1):63–65.
40. Studier FW, Moffatt BA: Use of bacteriophage T7 RNA polymerase to
direct selective high-level expression of cloned genes. J Mol Biol 1986,
189(1):113–130.
Balzer et al. Microbial Cell Factories 2013, 12:26 Page 14 of 14
http://www.microbialcellfactories.com/content/12/1/2641. Schlesinger MJ: Secretion of alkaline phosphatase subunits by
spheroplasts of Escherichia coli. J Bacteriol 1968, 96(3):727–733.
42. Vethanayagam JGG, Flower AM: Decreased gene expression from T7
promoters may be due to impaired production of active T7 RNA
polymerase. Microb Cell Fact 2005, 4(1):113–130.
43. Taniguchi Y, Choi PJ, Li GW, Chen H, Babu M, Hearn J, Emili A, Xie XS:
Quantifying E. coli proteome and transcriptome with single-molecule
sensitivity in single cells. Science 2010, 329(5991):533–538.
44. Bernstein JA, Khodursky AB, Lin PH, Lin-Chao S, Cohen SN: Global analysis
of mRNA decay and abundance in Escherichia coli at single-gene
resolution using two-color fluorescent DNA microarrays. Proc Natl Acad
Sci USA 2002, 99(15):9697–9702.
45. Laursen BS, Sørensen HP, Mortensen KK, Sperling-Petersen HU: Initiation of
protein synthesis in bacteria. Microbiol Mol Biol Rev 2005, 69(1):101–123.
46. Lim HK, Jung KH, Park DH, Chung SI: Production characteristics of
interferon-α using an L-arabinose promoter system in a high-cell-density
culture. Appl Microbiol Biotechnol 2000, 53(2):201–208.
47. Saida F, Uzan M, Odaert B, Bontems F: Expression of highly toxic genes in E.
coli: special strategies and genetic tools. Curr Protein Pept Sci 2006, 7(1):47–56.
48. Chen H, Bjerknes M, Kumar R, Jay E: Determination of the optimal aligned
spacing between the Shine-Dalgarno sequence and the translation initiation
codon of Escherichia coli mRNAs. Nucleic Acids Res 1994, 22(23):4953–4957.
49. de Smit MH, van Duin J: Translational initiation on structuredmessengers.
Another role for the Shine-Dalgarno interaction. J Mol Biol 1994, 235(1):173–184.
50. Barrick D, Villanueba K, Childs J, Kalil R, Schneider TD, Lawrence CE, Gold L,
Stormo GD: Quantitative analysis of ribosome binding sites in E. coli.
Nucleic Acids Res 1994, 22(7):1287–1295.
51. Walker KA, Osuna R: Factors affecting start site selection at the Escherichia
coli fis promoter. J Bacteriol 2002, 184(17):4783–4791.
52. Lewis DEA, Adhya S: Axiom of determining transcription start points by
RNA polymerase in Escherichia coli. Mol Microbiol 2004, 54(3):692–701.
53. Vellanoweth RL, Rabinowitz JC: The influence of ribosome-binding-site
elements on translational efficiency in Bacillus subtilis and Escherichia coli
in vivo. Mol Microbiol 1992, 6(9):1105–1114.
54. Salis HM, Mirsky EA, Voigt CA: Automated design of synthetic ribosome binding
sites to control protein expression. Nat Biotechnol 2009, 27(10):946–950.
55. Komarova AV, Tchufistova LS, Dreyfus M, Boni IV: AU-rich sequences within
5´ untranslated leaders enhance translation and stabilize mRNA in
Escherichia coli. J Bacteriol 2005, 187(4):1344–1349.
56. Osterman IA, Evfratov SA, Sergiev PV, Dontsova OA: Comparison of mRNA
features affecting translation initiation and reinitiation. Nucleic Acids Res
2012, 41(1):474–486.
57. Raj A, van Oudenaarden A: Nature, nurture, or chance: stochastic gene
expression and its consequences. Cell 2008, 135(2):216–226.
58. Eldar A, Elowitz MB: Functional roles for noise in genetic circuits. Nature
2010, 467(7312):167–173.
59. Keasling JD: Gene-expression tools for the metabolic engineering of
bacteria. Trends Biotechnol 1999, 17(11):452–460.
60. Zhao Y, He W, Liu WF, Liu CC, Feng LK, Sun L, Yan YB, Hang HY: Two
distinct states of Escherichia coli cells that overexpress recombinant
heterogeneous beta-galactosidase. J Biol Chem 2012, 287(12):9259–9268.
61. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual.
2nd edition. New York: Cold Spring Harbor Laboratory Press; 1989.
62. Aune TEV, Bakke I, Drabløs F, Lale R, Brautaset T, Valla S: Directed evolution
of the transcription factor XylS for development of improved expression
systems. Microb Biotechnol 2009, 3(1):38–47.
63. EMBL Protein Expression and Purification Core Facility. www.embl.de/pepcore/.
64. Miyada CG, Stoltzfus L, Wilcox G: Regulation of the araC gene of
Escherichia coli: catabolite repression, autoregulation, and effect on
araBAD expression. Proc Natl Acad Sci USA 1984, 81(13):4120–4124.
65. Schein CH, Noteborn MHM: Formation of soluble recombinant proteins in
Escherichia coli is favored by lower growth temperature. Nat Biotechnol
1988, 6(3):291–294.
66. Winther-Larsen HC, Blatny JM, Valand B, Brautaset T, Valla S: Pm promoter
expression mutants and their use in broad-host-range RK2 plasmid
vectors. Metab Eng 2000, 2(2):92–103.
doi:10.1186/1475-2859-12-26
Cite this article as: Balzer et al.: A comparative analysis of the properties
of regulated promoter systems commonly used for recombinant gene
expression in Escherichia coli. Microbial Cell Factories 2013 12:26.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
